| Trial ID: | L0580 |
| Source ID: | ChiCTR-IPR-16008718
|
| Associated Drug: |
Levocarnitine
|
| Title: |
A randomized, placebo-controlled clinical study to evaluate the efficacy of Levocarnitine in the treatment of nonalcoholic fatty liver disease.
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
nonalcoholic fatty liver disease
|
| Interventions: |
treantment group:Levocarnitine 1g, bid., po., 12wks;2:no;
|
| Outcome Measures: |
ALT level;GGT;the ration of patients whose ALT decrease to normal;AST;HOMA-IR;TG;TC;HDL-C;LDL-C;Fasting blood glucose;CAP;
|
| Sponsor/Collaborators: |
Beijing Youan Hospital, Capital Medical University
|
| Gender: |
All
|
| Age: |
1870
|
| Phases: |
Post-market
|
| Enrollment: |
treantment group:36;2:36;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
25/06/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
18 April 2017
|
| Locations: |
China mainland
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=14742
|
